跳至主要内容
临床试验/CTIS2022-501858-11-00
CTIS2022-501858-11-00招募中1 期

Remifentanil for endotracheal intubation in neonates: a dose-finding trial. - BC-09897

niversitair Ziekenhuis Gent0 个研究点目标入组 50 人开始时间: 2022年10月20日最近更新:

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 17(—)
性别
All

入选标准

  • Hemodynamic stable term or preterm neonate (normal mean blood pressure, without use of inotropic agents or vasopressors., Requiring semi-elective endotracheal intubation., Minimum of 26 weeks gestational age., Written informed consent obtained from the legal representatives.

排除标准

  • 5th min Apgar score less than 5., Maxillofacial anomalies., Anticipated difficult airwaiy (e.g. airway anomaly or obstruction)., Concurrent or recent intravenous opioids infusions within 24 hours of the procedure., Neonates from non-Dutch speaking parents, Infants born via cesarian section under general anesthesia 12 hours prior to enrollment., Neonates from mothers with recent drug abuse, Prior enrollment in the trial.

研究者

发起方
niversitair Ziekenhuis Gent

相似试验